NL-OMON38870
Completed
Not Applicable
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a two-part clinical study. Part A: Multisite MRI Acquisition - Protocol Harmonization Part B: Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a clinical study - PharmaCog
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with a diagnosis of Mild Cognitive Impairment, aged 55\-90 years and memory complaints verified by a physician and on cognitive testing.
Exclusion Criteria
- •Ischaemic lesions
- •Head injury with loss of consciousness \> 24 hours
- •Current substance abuse or therapy with steroids or chemotherapy
- •Systemic disease with frequent involvement of the CNS
- •CNS disease diagnosed or in treatment
- •Inadequate for neuropsychological testing
- •Enrolment in other trials/studies not compatible with this study
- •Use of specific medication
- •(History of) neurological/psychiatric illnesses
- •Ferromagnetic implants and devices not eligible for MRI scanning
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment. Two-Part Research: Part BF00.2Alzheimer's diseaseMild Cognitive ImpairmentF00.0F00.1F00.9F06.7Dementia in Alzheimer disease with early onsetDementia in Alzheimer disease with late onsetDementia in Alzheimer disease, atypical or mixed typeDementia in Alzheimer disease, unspecifiedMild cognitive disorderDRKS00003705QUALISSIMA150
Completed
Not Applicable
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment. Two-part Research: Part AHealthy SubjectsMild Cognitive ImpairmentAlzheimer's disease / Alzheimer dementiaF00.0F00.1F00.2F00.9F06.7Dementia in Alzheimer disease with early onsetDementia in Alzheimer disease with late onsetDementia in Alzheimer disease, atypical or mixed typeDementia in Alzheimer disease, unspecifiedMild cognitive disorderDRKS00003721QUALISSIMA40
Recruiting
Not Applicable
Identification of biomarkers for diagnosis and prognosis in the patients with obstructive sleep apneaobstructive sleep apneaJPRN-UMIN000021503Osaka university graduate School of medicine The department of geriatric and general medicine200
Completed
Not Applicable
Elucidation of biomarkers to predict the presence of coronary vulnerable plaqueJPRN-UMIN000009806agasaki University Graduate School of Biomedical Sciences200
Completed
Not Applicable
Identification of biomarkers, functional parameters and clinical risk factors predisposing for the development of pulmonary chronic GVHD after allogeneic hematopoietic stem cell transplantation.obliterative bronchiolitis, bronchiolitis obliterans with organizing pneumonia (BOOP), non-classifiable interstitial pneumonia (NCIP)chronic GVHD, ICD-10: T86.05, T86.06, T86.07T86.06DRKS00003304Westdeutsches TumorzentrumKlinik für KnochenmarktransplantationUniversitätsklinikum Essen125